SLNO FY2025 EPS Forecast Decreased by Cantor Fitzgerald
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) – Equities researchers at Cantor Fitzgerald lowered their FY2025 EPS estimates for Soleno Therapeutics in a research note issued to investors on Thursday, March 27th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earnings per share of ($2.85) for the year, down from their […]
